141286-91-1Relevant articles and documents
Synthesis and evaluation of novel fluorinated sulotroban-related sulfonamide derivatives as thromboxane A2 receptor antagonists
Sato,Kawashima,Goto,Yamane,Chiba,Jinno,Satake,Iwata
, p. 403 - 414 (1995)
A series of sulotroban-related arylsulfonamide derivatives possessing a fluorinated phenoxyacetic acid moiety was synthesized and tested for TXA2 antagonizing ability on U-46619-induced platelet aggregation of rabbit platelet-rich plasma. Introduction of one or more fluorine atoms to the phenoxyacetic acid moiety increased this activity. The most potent compound among these compounds was 10c, which was 40-fold more potent (IC50 3.4 x 10-7 M) than sulotroban. 10c exhibited high activity (ID50 0.14 mg/kg) against a D-46619-induced acute thrombocytopenia model in mice when orally administrated. These findings and those of radioligand binding assays with various ligands showed 10c to be a potent and selective systemic TXA2 receptor antagonist.
In vivo AMPA receptors in the brain imaging method of primates, program, and screening method
-
Paragraph 0089-0090, (2018/06/30)
This imaging method of AMPA receptors in the brain of primate organisms involves a step in which a substance which is administered to the primate organism and which selectively bonds to AMPA receptors in the brain of the primate organism and has a radiola
Sulfonamide derivatives
-
, (2008/06/13)
A sulfonamide derivative represented by the Formula: STR1 wherein A, B, X, Y, R, m and n are as defined in the specification, and a salt thereof have thromboxane A2 antagonism, therefore they are useful, for example, as blood platelet aggregati